S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling

Journal of Biological Chemistry

Volumn 289, Issue 2, 2014, Pages 827-837

  Xu, Chengshan ^a   Chen, Hongyan ^a   Wang, Xiang ^b   Gao, Jidong ^b   Che, Yiqun ^c   Li, Yi ^a   Ding, Fang ^a   Luo, Aiping ^a   Zhang, Shuguang ^a   Zhang, Zhihua Liu ^a  

^a State Key Laboratory of Molecular Oncology   (China)

^b Department of Abdominal Surgery ^*  (China)

^c CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CALCIUM BINDING PROTEINS; EF-HAND; HUMAN EPIDERMAL GROWTH FACTOR; TUMORIGENESIS;

CELL PROLIFERATION;

DISEASES;

CALCIUM BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN S100A14; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; SURVIVAL TIME;

BREAST CANCER; CELL PROLIFERATION; PROTEIN PHOSPHORYLATION; PROTEIN-PROTEIN INTERACTIONS; S100 PROTEINS;

BLOTTING, WESTERN; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; EF HAND MOTIFS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MCF-7 CELLS; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROTEIN BINDING; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 84891936355     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.469718     Document Type: Article

References (43)

1. Yarden, Y., and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137
2. Nahta, R., and Esteva, F. J. (2006) Herceptin. Mechanisms of action and resistance. Cancer Lett. 232, 123-138
3. Olayioye, M. A., Neve, R. M., Lane, H. A., and Hynes, N. E. (2000) The ErbB signaling network. Receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167
4. Graus-Porta, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16, 1647-1655
5. Santamaria-Kisiel, L., Rintala-Dempsey, A. C., and Shaw, G. S. (2006) Calcium-dependent and-independent interactions of the S100 protein family. Biochem. J. 396, 201-214
6. Salama, I., Malone, P. S., Mihaimeed, F., and Jones, J. L. (2008) A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357-364
7. Donato, R. (2001) S100. A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668
8. Pietas, A., Schlüns, K., Marenholz, I., Schäfer, B. W., Heizmann, C. W., and Petersen, I. (2002) Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 79, 513-522
9. Wang, H. Y., Zhang, J. Y., Cui, J. T., Tan, X. H., Li, W. M., Gu, J., and Lu, Y. Y. (2010) Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol. Rep. 23, 45-52
10. Leth-Larsen, R., Terp, M. G., Christensen, A. G., Elias, D., Kühlwein, T., Jensen, O. N., Petersen, O. W., and Ditzel, H. J. (2012) Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol. Med. 18, 1109-1121
11. Smirnov, D. A., Zweitzig, D. R., Foulk, B. W., Miller, M. C., Doyle, G. V., Pienta, K. J., Meropol, N. J., Weiner, L. M., Cohen, S. J., Moreno, J. G., Connelly, M. C., Terstappen, L. W., and O'Hara, S. M. (2005) Global gene expression profiling of circulating tumor cells. Cancer Res. 65, 4993-4997
12. Chen, H., Yuan, Y., Zhang, C., Luo, A., Ding, F., Ma, J., Yang, S., Tian, Y., Tong, T., Zhan, Q., and Liu, Z. (2012) Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation. J. Biol. Chem. 287, 17109-17119
13. Jin, Q., Chen, H., Luo, A., Ding, F., and Liu, Z. (2011) S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One 6, e19375
14. Arumugam, T., Simeone, D. M., Schmidt, A. M., and Logsdon, C. D. (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J. Biol. Chem. 279, 5059-5065
15. Tulchin, N., Chambon, M., Juan, G., Dikman, S., Strauchen, J., Ornstein, L., Billack, B., Woods, N. T., and Monteiro, A. N. (2010) BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. Am. J. Pathol. 176, 1203-1214
16. Duverger, O., Lee, D., Hassan, M. Q., Chen, S. X., Jaisser, F., Lian, J. B., and Morasso, M. I. (2008) Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome. J. Biol. Chem. 283, 20198-20208
17. Song, E. J., Werner, S. L., Neubauer, J., Stegmeier, F., Aspden, J., Rio, D., Harper, J. W., Elledge, S. J., Kirschner, M. W., and Rape, M. (2010) The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes Dev. 24, 1434-1447
18. Luo, W., Liu, J., Li, J., Zhang, D., Liu, M., Addo, J. K., Patil, S., Zhang, L., Yu, J., Buolamwini, J. K., Chen, J., and Huang, C. (2008) Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway. J. Biol. Chem. 283, 8624-8633
19. Zhang, X. H., Wang, Q., Gerald, W., Hudis, C. A., Norton, L., Smid, M., Foekens, J. A., and Massagué, J. (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67-78
20. Bos, P. D., Zhang, X. H., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., and Massague ́, J. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009
21. Yu, C. S., Chen, Y. C., Lu, C. H., and Hwang, J. K. (2006) Prediction of protein subcellular localization. Proteins 64, 643-651
22. Adam, P. J., Boyd, R., Tyson, K. L., Fletcher, G. C., Stamps, A., Hudson, L., Poyser, H. R., Redpath, N., Griffiths, M., Steers, G., Harris, A. L., Patel, S., Berry, J., Loader, J. A., Townsend, R. R., Daviet, L., Legrain, P., Parekh, R., and Terrett, J. A. (2003) Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J. Biol. Chem. 278, 6482-6489
23. Moasser, M. M. (2007) The oncogene HER2. Its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 26, 6469-6487
24. Baselga, J., and Swain, S. M. (2009) Novel anticancer targets. Revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9, 463-475
25. Cianfrocca, M., and Goldstein, L. J. (2004) Prognostic and predictive factors in early-stage breast cancer. Oncologist 9, 606-616
26. Wang, Y. Y., Ye, Z. Y., Zhao, Z. S., Tao, H. Q., and Chu, Y. Q. (2010) High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann. Surg. Oncol. 17, 89-97
27. Zhang, H. Y., Zheng, X. Z., Wang, X. H., Xuan, X. Y., Wang, F., and Li, S. S. (2012) S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity. Mol. Biol. Rep. 39, 199-208
28. Vimalachandran, D., Greenhalf, W., Thompson, C., Lüttges, J., Prime, W., Campbell, F., Dodson, A., Watson, R., Crnogorac-Jurcevic, T., Lemoine, N., Neoptolemos, J., and Costello, E. (2005) High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res. 65, 3218-3225
29. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Tsukahara, Y., Kojima, M., Uchiyama, A., Kuroki, S., Torisu, M., and Tanaka, M. (1998) Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas. Pre-operative determination of malignant potential. Eur. J. Surg. Oncol. 24, 28-33
30. Mittra, I., Redkar, A. A., and Badwe, R. A. (1995) Prognosis of breast cancer. Evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes. J. Surg. Oncol. 60, 106-111
31. Tokatli, F., Altaner, S., Uzal, C., Ture, M., Kocak, Z., Uygun, K., and Bilgi, S. (2005) Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients. Exp. Oncol. 27, 145-149
32. Schneider, J., Pollán, M., Tejerina, A., Sánchez, J., and Lucas, A. R. (2003) Accumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer. Br. J. Cancer 88, 96-101
33. Bader, A. A., Tio, J., Petru, E., Bühner, M., Pfahlberg, A., Volkholz, H., and Tulusan, A. H. (2002) T1 breast cancer. Identification of patients at low risk of axillary lymph node metastases. Breast Cancer Res. Treat. 76, 11-17
34. Sütterlin, M. W., Haller, A., Gassel, A. M., Peters, K., Caffier, H., and Dietl, J. (2000) The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer. Anticancer Res. 20, 5083-5088
35. Arisio, R., Sapino, A., Cassoni, P., Accinelli, G., Cuccorese, M. C., Mano, M. P., and Bussolati, G. (2000) What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas? J. Clin. Pathol. 53, 846-850
36. Erjala, K., Sundvall, M., Junttila, T. T., Zhang, N., Savisalo, M., Mali, P., Kulmala, J., Pulkkinen, J., Grenman, R., and Elenius, K. (2006) Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Clin. Cancer Res. 12, 4103-4111
37. Li, H., Sánchez-Torres, J., Del Carpio, A., Salas, V., and Villalobo, A. (2004) The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein. Biochem. J. 381, 257-266
38. Nahta, R., Hung, M. C., and Esteva, F. J. (2004) The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells. Cancer Res. 64, 2343-2346
39. Shattuck, D. L., Miller, J. K., Carraway, K. L., 3rd, and Sweeney, C. (2008) Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res. 68, 1471-1477
40. Wainberg, Z. A., Anghel, A., Desai, A. J., Ayala, R., Luo, T., Safran, B., Fejzo, M. S., Hecht, J. R., Slamon, D. J., and Finn, R. S. (2010) Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. Clin. Cancer Res. 16, 1509-1519
41. Klingelhöfer, J., Møller, H. D., Sumer, E. U., Berg, C. H., Poulsen, M., Kiryushko, D., Soroka, V., Ambartsumian, N., Grigorian, M., and Lukanidin, E. M. (2009) Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein. FEBS J. 276, 5936-5948
42. Hernan, R., Fasheh, R., Calabrese, C., Frank, A. J., Maclean, K. H., Allard, D., Barraclough, R., and Gilbertson, R. J. (2003) ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res. 63, 140-148
43. Paruchuri, V., Prasad, A., McHugh, K., Bhat, H. K., Polyak, K., and Ganju, R. K. (2008) S100A7-downregulation inhibits epidermal growth factorinduced signaling in breast cancer cells and blocks osteoclast formation. PLoS One 3, e1741